108 studies found for:    "Motor neuro-ophthalmic disorders"
Show Display Options
RSS Create an RSS feed from your search for:
"Motor neuro-ophthalmic disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation and Treatment of Pediatric Eye Diseases
Condition: Ocular Motility Disorder
Intervention: Procedure: current standard of care treatments
2 Completed Eye Teaming Evaluation Study
Condition: Convergence Insufficiency
Intervention: Device: NPC targets
3 Unknown  Convergence Insufficiency Treatment Trial (CITT)
Conditions: Convergence Insufficiency;   Binocular Vision Disorder
Interventions: Behavioral: Home-based Pencil Push-Up Therapy;   Behavioral: Home-based Pencil Push-ups with Computer Vision Therapy/Orthoptics;   Behavioral: Office-based Vision Therapy/Orthoptics;   Behavioral: Placebo Office-based Vision Therapy/Orthoptics
4 Completed Study of Eyes and Attention Deficit (SEAD)
Conditions: ADHD;   Convergence Insufficiency;   Accommodative Insufficiency
Intervention:
5 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
6 Recruiting Convergence Insufficiency Treatment Study (CITS)
Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
7 Completed Randomized Trial of Treatments for Convergence Insufficiency
Condition: Convergence Insufficiency
Interventions: Procedure: Pencil Push-ups;   Procedure: Office-based Vision Therapy;   Procedure: Placebo Office-based Vision Therapy
8 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
9 Recruiting Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
Conditions: Opsoclonus Myoclonus Syndrome;   Neuroblastoma
Interventions: Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
10 Completed Surgery and Convergence Insufficiency Intermittent Exotropia
Condition: Complications
Interventions: Procedure: Post exercise Surgery;   Procedure: Orthoptics;   Procedure: Postop orthoptics;   Procedure: Post exercises surgery
11 Completed A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
Condition: Convergence Insufficiency
Interventions: Procedure: Base-in prism glasses for reading;   Procedure: Placebo reading glasses
12 Recruiting MRI Study Looking at Resting Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
13 Recruiting Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
Condition: Opsoclonus-myoclonus Syndrome
Intervention:
14 Recruiting Study of Non-surgical Treatment Versus Observation in Asian Children With Intermittent Exotropia
Condition: Intermittent Exotropia
Intervention: Procedure: Non surgical therapy
15 Completed Risk Factors for Progressive Supranuclear Palsy (PSP)
Condition: Progressive Supranuclear Palsy
Intervention:
16 Completed Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Condition: Infantile Nystagmus Syndrome
Interventions: Drug: topical brinzolamide 1% in 5mL ophthalmic medication;   Drug: Placebo in 5 mL dispenser
17 Completed Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: GDNF & Synchro Med Infusion System
18 Active, not recruiting Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia
Condition: Exotropia
Interventions: Procedure: Bilateral lateral rectus recession (BLRrec);   Procedure: Unilateral lateral rectus recession with medial rectus resection (R&R)
19 Recruiting Early Versus Delayed Surgery for Infantile Esotropia
Condition: Esotropia
Interventions: Procedure: mVEP Testing;   Procedure: Stereoacuity Testing;   Procedure: Optokinetic nystagmus testing;   Procedure: Motion detection testing;   Procedure: Motion discrimination testing
20 Completed Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
Condition: Esotropia
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years